Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Muldoon

Showing results (11-20 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Epidemiology|March 15, 1995
Invited commentary: low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: a search for causes and confoundersD R Jacobs, M F Muldoon, L Råstam
Experimental Aging Research|October 1, 1995
Neuropsychological consequences of antihypertensive medication useM F Muldoon, S R Waldstein, J R Jennings
Archives of Internal Medicine|July 1, 1991
Does cholesterol lowering increase non-illness-related mortality?M F Muldoon, S B Manuck, K A Matthews
BMJ (Clinical Research Ed.)|August 11, 1990
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trialsM F Muldoon, S B Manuck, K A Matthews
The New England Journal of Medicine|March 28, 1991
Mortality experience in cholesterol-reduction trialsM F Muldoon, S B Manuck, K A Matthews
Archives of Internal Medicine|May 29, 2000
White-coat hypertension and carotid artery atherosclerosis: a matching studyM F Muldoon, P Nazzaro, K Sutton-Tyrrell, et al.
Psychosomatic Medicine|April 20, 2000
Does socioeconomic status relate to central serotonergic responsivity in healthy adults?K A Matthews, J D Flory, M F Muldoon, et al.
Journal of Hypertension|June 1, 1991
Neurobehavioral effects of antihypertensive medicationsM F Muldoon, S B Manuck, A P Shapiro, et al.
Psychosomatic Medicine|July 1, 1997
Serum cholesterol and intellectual performanceM F Muldoon, C M Ryan, K A Matthews, et al.
Psychological Bulletin|November 1, 1991
Neuropsychological correlates of hypertension: review and methodologic considerationsS R Waldstein, S B Manuck, C M Ryan, et al.
Pageof 7

Showing results (11-20 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Epidemiology|March 15, 1995
Invited commentary: low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: a search for causes and confoundersD R Jacobs, M F Muldoon, L Råstam
Experimental Aging Research|October 1, 1995
Neuropsychological consequences of antihypertensive medication useM F Muldoon, S R Waldstein, J R Jennings
Archives of Internal Medicine|July 1, 1991
Does cholesterol lowering increase non-illness-related mortality?M F Muldoon, S B Manuck, K A Matthews
BMJ (Clinical Research Ed.)|August 11, 1990
Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trialsM F Muldoon, S B Manuck, K A Matthews
The New England Journal of Medicine|March 28, 1991
Mortality experience in cholesterol-reduction trialsM F Muldoon, S B Manuck, K A Matthews
Archives of Internal Medicine|May 29, 2000
White-coat hypertension and carotid artery atherosclerosis: a matching studyM F Muldoon, P Nazzaro, K Sutton-Tyrrell, et al.
Psychosomatic Medicine|April 20, 2000
Does socioeconomic status relate to central serotonergic responsivity in healthy adults?K A Matthews, J D Flory, M F Muldoon, et al.
Journal of Hypertension|June 1, 1991
Neurobehavioral effects of antihypertensive medicationsM F Muldoon, S B Manuck, A P Shapiro, et al.
Psychosomatic Medicine|July 1, 1997
Serum cholesterol and intellectual performanceM F Muldoon, C M Ryan, K A Matthews, et al.
Psychological Bulletin|November 1, 1991
Neuropsychological correlates of hypertension: review and methodologic considerationsS R Waldstein, S B Manuck, C M Ryan, et al.
Pageof 7